Dr. Levine on Immunotherapy for Endometrial Cancer

Douglas A. Levine, MD, professor, Department of Obstetrics and Gynecology, director, Division of Gynecologic Oncology, NYU Langone's Perlmutter Cancer Center, discusses immunotherapy for patients with endometrial cancer.

Immunotherapy has capitalized on what was already known regarding endometrial cancer, states Levine.

Some microsatellite instability-high tumors are inherited through a defect in mismatch-repair genes, which is important for genetic screening. There is another link between inherited genetic events that are leading to effective treatments, states Levine.